# Epigenetic Testing for Breast Cancer Risk Stratification

> **NCT01501656** · — · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 158 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01501656
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2016-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01501656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01501656, "Epigenetic Testing for Breast Cancer Risk Stratification". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01501656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*